Surgical Site Infection Control Market Overview
The global surgical site infection control market was valued at USD 3706.7 million in 2017, is expected to witness a CAGR of 5.65% over the period, 2018-2023 (henceforth, the forecast period). Surgical site infection (SSI) is an infection that occurs after surgery in the part of the body where the surgery was conducted. Surgical site infections can be superficial, deep incisional, or organ related. A rise in hospital-acquired infection and regulatory guidelines for hospital infection prevention and control are expected to boost the global market. North America accounts for the largest share of the SSI market. This can be primarily attributed to the growing geriatric population and increasing demand for non-invasive aesthetic procedures, which are expected to augment the growth of the market studied over the forecast period.
Rise in Hospital Acquired Infection to Boost Surgical Site Infection (SSI) Market Growth
Hospital-acquired infections (HAIs) are the most common complications in hospitalized patients, with an estimated incidence of 4.5 HAIs per 100 hospital admissions and an annual cost ranging between USD 35 billion and USD 45 billion. These HAIs are also called nosocomial infection. According to the Centers for Disease Control and Prevention (CDC), about one in every 20 patients who are admitted for the treatment will develop a nosocomial infection. Hospital-acquired infections result in more than 99,000 deaths each year. HAIs are ranked among the top five leading causes of death in the United States. Some of the most common hospital-acquired infection cases include - surgical infections, respiratory infections, urinary tract infections, and bloodstream infections. Post-surgery bloodstream infections have increased by 8%, while urinary tract infections following the use of a catheter after surgery have increased by 3.6%, as per the American Hospital Association.
It is estimated 157,500 SSIs were associated with inpatient surgeries in 2011, as per the prevalence survey on HAIs, by CDC, various steps are undertaken by the government, to control and prevent HAIs. Healthcare facilities, care teams, and individual doctors and nurses are also aware of infection-related issues and take specific steps to prevent them. The rates of some targeted HAIs can decrease by more than 70%.
Therefore, due to the increased incidence of hospital-acquired infections, there is an alarming need to prevent them, which acts as a major driving factor for the growth of the market. The other factors such as regulatory guidelines for hospital infection prevention and control, increasing number of surgeries and the rapidly growing geriatric population is also driving the market.
Lack of Awareness of Hospital-Acquired Infection Prevention and Control to Hinder Market Growth
Surgical site infections (SSIs) are important public health problems. They exert increased morbidity and mortality and increase the healthcare cost, both in developed and developing countries. One of the major reasons for these high rates of hospital infection is the lack of infection control programs, which have been neglected due to limited resources, challenging priorities, and other barriers. It was stated by the International Nosocomial Infection Control Consortium that the pooled rate of central line-associated bloodstream infections in the intensive care units in Latin America, Asia-Pacific, Africa, and Europe was 4.9 per 1,000 central line days, nearly fivefold higher than the rate reported from comparable US intensive care units. Therefore, it is essential for medical students to have adequate knowledge about infection prevention and control (IPC) practices and to incorporate these in the professional training of medical students. There is a lack of evidence regarding explicit infection control training in the curriculum of most medical undergraduate courses, which needs to be addressed if hospital-acquired infections rates are to be reduced.
Thus, the lack of awareness of hospital-acquired infections is acting as a major contributing factor for the growth of these infections. Less usage of HAI prevention- and control-related products during surgeries is restraining the growth of the market studied. And the other factor such as increased use of outpatient treatment is also restraining the market.
Report Coverage & Deliverables
In 2017 the others in the product segment have the largest share in the SSI market which is 33%. The other products include infection prevention services and sterilization equipment, washing/disinfecting equipment, and other equipment. Surgical gloves are growing with the fastest CAGR during the forecast period. Surgical gloves are standard practice to prevent postoperative infection and reduce the risk of harm to the patient. Manual reprocessors solution is also growing as these solutions are crucial for the validation of the processes and patient safety. Skin disinfectants are also useful in the prevention of SSIs. Hence, need for the development of cost-effective and efficient methods for eliminating SSIs has been driving research and development activities in this product segment.
Among all the surgery or procedure the others segment has the largest share in the SSI market which is 38%. Others surgery includes orthopedic surgery. Dental Restoration segment is growing with the fastest CAGR during the forecast period. In cataract, 95% of the surgeries are successful with fewer than 5% of cases experiencing complications, such as inflammation, bleeding, infection, and retinal detachment. Endophthalmitis is a rare, but serious, postoperative complication of cataract surgery. It can have a devastating consequence on a patient's vision, as some patients may lose all light perception. The risk factors, associated with Cesarean Section, are more, the chances of surgical site infection are even more, which, ultimately, increases the use of products that are used for surgical site infection control. Also, most of the SSIs following gastric bypass occur within the first 2-3 weeks of surgery. The most common source of pathogens causing SSIs post-gastrointestinal surgeries is endogenous patient flora (including staphylococcal and streptococcal species) and flora of the gastrointestinal tract (including aerobic and anaerobic Gram-negative bacilli). So, due to increasing number of surgeries or procedure will augment the growth of the market globally.
Type of Infection Insight
In the type of infection superficial incisional SSI infection dominated the market as it infection occurs only in the area of the skin where the incision was made within 30 days after the operation. Deep incisional SSI is growing with the highest CAGR of 5.78%. Organ or space SSI infection can be in any area of the body other than skin, muscle, and surrounding tissue, involved in the surgery.
The hospitals have the maximum number of preventive products for the SSI control and thus dominates the end-user segment. Ambulatory surgery centers (ASC) performs surgeries which are commonly less complicated than the requiring hospitalization which is safer for surgery as it has control over their environment.
North America accounts for the largest share of the market studied. This can be primarily attributed to the growing geriatric population and increasing demand for non-invasive aesthetic procedures, which are expected to augment the growth of the market studied over the forecast period.
Key Developments in Surgical Site Infections (SSI) Control Market
- Nov 2017: The Company announced the launch of Belimed Protect, a new portfolio of cleaning and disinfecting solutions, after its strategic partnership with B Braun Medical AG.
- Jan 2018: Johnson & Johnson partnered with Maharashtra government on health interventions collaboration would also look at infection prevention, diabetes, obesity, and menstrual hygiene and support healthcare professionals and nurses
The major companies include 3M Company, Becton, Dickinson and Company, Belimed AG, Biomerieux SA, Getinge Group, Johnson & Johnson, Kimberly-Clark, Sotera Health, Ansell Limited, Steris Corporation, Lac-Mac Limited, Pacon Manufacturing Corp. and American Polyfilm Inc.among others.
Surgical Site Infections (SSI) Control Market Segmentation
- By Product
- Manual Reprocessors Solution
- Hand Disinfectants
- Skin Disinfectants
- Surgical Scrubs
- Hair Clippers
- Surgical Drapes
- Surgical Irrigation
- Skin Preparation Solution
- Medical Nonwovens
- Surgical Gloves
- By Surgery/Procedure
- Cataract Surgery
- Cesarean Section
- Dental Restoration
- Gastric Bypass
- By Type of Infection
- Superficial Incisional SSI
- Deep Incisional SSI
- Organ or Space SSI
- By End User
- Ambulatory Surgical Centers
- By Geography
- North America
- Asia Pacific
- South Korea
- Middle East and Africa
- South Africa
- South America
- North America
Country-Level Data Points Coverage and Deliverables for Surgical Site Infection (SSI) Control Market
Surgical Site Infection (SSI) Control Market Report Summary
Surgical Site Infection (SSI) Control Market
(2015 – 2023)
By Product includes Manual Reprocessors Solution, Disinfectants, Surgical Scrubs, Hair Clippers, Surgical Drapes, Surgical Irrigation, Skin Preparation Solution, Medical Nonwovens, Surgical Gloves and others.
By Surgery/Procedure includes Cataract Surgery, Cesarean Section, Dental Restoration, Gastric Bypass and others.
By Type of Infection includes Superficial, Deep and Organ or Space Incisional SSI
By End-User includes Hospitals and Ambulatory Surgical Centers
North America (US, Canada, Mexico), Europe (UK, Germany, France, Italy Spain, Rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea and Rest of Asia Pacific), Middle East & Africa (GCC, South Africa and Rest of MEA) and South America (Brazil, Argentina and Rest of South America)
Nov 2017: The Company announced the launch of Belimed Protect, a new portfolio of cleaning and disinfecting solutions, after its strategic partnership with B Braun Medical AG.
3M Company, Becton, Dickinson and Company, Belimed AG, Biomerieux SA, Getinge Group, Johnson & Johnson, Kimberly-Clark, Sotera Health, Ansell Limited, Steris Corporation, Lac-Mac Limited, Pacon Manufacturing Corp. and American Polyfilm Inc.among others.
Surgical Site Infection (SSI) Control Market offers latest trends, growth prospects, industry competitiveness, major players, regional share of market and forecast to 2023.
Reasons to Purchase the Surgical Site Infection Control Market Report
- Current and future of surgical site infection control market outlook in the developed and emerging markets
- Analysis of various perspectives of the market with the help of Porter’s five forces analysis
- The segment that is expected to dominate the market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, market shares, and strategies employed by the major market players
- 3-month analyst support, along with the market estimate sheet (in Excel)
Customization of the Surgical Site Infection Control Market Report
- This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs
1.1 Market Definition
2. Research Methodology of Surgical Site Infection Control Market
3. Executive Summary of Surgical Site Infection Control Market
4. Key Inferences of Surgical Site Infection Control Market
5. Market Overview of Surgical Site Infection Control Market
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Degree of Competition
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
6.1 Surgical Site Infection Control Market Drivers
6.1.1 Rise In Hospital Acquired Infection
6.1.2 Regulatory Guidelines for Hospital Infection Prevention and Control
6.1.3 Increasing Number of Surgeries
6.1.4 Rapidly Growing Geriatric Population
6.2 Surgical Site Infection Control Market Restraints
6.2.1 Lack of Awareness of Hospital Infection Prevention and Control
6.2.2 Increased Use of Outpatient Treatment
6.3 Surgical Site Infection Control Market Opportunities
6.4 Key Challenges in Surgical Site Infection Control Market
7. Market Segmentation
7.1 Surgical Site Infection Control Market By Product
7.1.1 Manual Reprocessors Solution
126.96.36.199 Hand Disinfectants
188.8.131.52 Skin Disinfectants
7.1.3 Surgical Scrubs
7.1.4 Hair Clippers
7.1.5 Surgical Drapes
7.1.6 Surgical Irrigation
7.1.7 Skin Preparation Solution
7.1.8 Medical Nonwovens
7.1.9 Surgical Gloves
7.2 Surgical Site Infection Control Market By Surgery/Procedure
7.2.1 Cataract Surgery
7.2.2 Cesarean Section
7.2.3 Dental Restoration
7.2.4 Gastric Bypass
7.3 Surgical Site Infection Control Market By Type of Infection
7.3.1 Superficial Incisional SSI
7.3.2 Deep Incisional SSI
7.3.3 Organ or Space SSI
7.4 Surgical Site Infection Control Market By End User
7.4.2 Ambulatory Surgical Centers
7.5 Surgical Site Infection Control Market By Geography
7.5.1 North America
184.108.40.206 United States
220.127.116.11 United Kingdom
18.104.22.168 Rest of Europe
22.214.171.124 Australia and New Zealand
126.96.36.199 South Korea
188.8.131.52 Rest of Asia-Pacific
7.5.4 South America
184.108.40.206 Rest of South America
7.5.5 Middle East and Africa
220.127.116.11 GCC Countries
18.104.22.168 South Africa
22.214.171.124 Rest of Middle East And Africa
8. Competitive Landscape of Surgical Site Infection Control Market
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players in Surgical Site Infection Control Market
9.1 3M Company
9.2 Becton, Dickinson and Company
9.3 Belimed AG
9.4 Biomerieux SA
9.5 Getinge Group
9.6 Johnson & Johnson
9.8 Sotera Health
9.9 Ansell Limited
9.10 Steris Corporation
9.11 Lac-Mac Limited
9.12 Pacon Manufacturing Corp.
9.13 American Polyfilm Inc
*List not Exhaustive
10. Future Outlook of Surgical Site Infection Control Market